Understanding how protein synthesis affects memory and brain disorders
Translational Control in Memory and Brain Disorders
['FUNDING_OTHER'] · NEW YORK UNIVERSITY · NIH-11080387
This study is looking at how certain proteins in the brain help with memory and how changes in these proteins might affect conditions like Alzheimer's and autism, using animal models to better understand these processes.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11080387 on ClinicalTrials.gov |
What this research studies
This research investigates the role of specific proteins in memory processes and how their regulation can impact conditions like Alzheimer's disease and autism spectrum disorder. By studying the signaling pathways that control protein synthesis in the brain, particularly in areas related to memory, the research aims to identify the cell types involved in these processes. The approach includes using animal models to explore how these mechanisms contribute to memory formation and dysfunction in neurodegenerative and developmental disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or autism spectrum disorder.
Not a fit: Patients with memory disorders not related to Alzheimer's disease or autism spectrum disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for improving memory and cognitive function in patients with Alzheimer's disease and autism spectrum disorder.
How similar studies have performed: Previous research has shown promising results in understanding the role of protein synthesis in memory, indicating that this approach has potential for significant advancements.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KLANN, ERIC — NEW YORK UNIVERSITY
- Study coordinator: KLANN, ERIC
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease, Alzheimer's disease model